among aml cases , the complete remission ( cr ) rate by intensive chemotherapy with daunorubicin and cytosine arabinoside was significantly lower in type iii ( 11 % ) than in types i ( 87 % ) and ii ( 71 % ) .
C0023467
aml
C0011015
daunorubicin